Nathan Reiff, Contributing Author at MarketBeat Articles by Nathan Reiff - Page 6March 3, 2025 5:54 AM ETOne Value, One Growth, and One Momentum Stock For DiversificationNathan ReiffPicking top stocks across value, growth, and momentum factors can help to diversify a portfolio and minimize risk while gaining exposure to multiple industries.NASDAQ:DDINASDAQ:GCTNASDAQ:SPCBRead One Value, One Growth, and One Momentum Stock For DiversificationFebruary 26, 2025 10:20 AM ETAST SpaceMobile Stock Surges 17% After Analyst UpgradeNathan ReiffAST SpaceMobile shares skyrocketed after an analyst upgrade and the announcement of a new government contract; can the firm continue to live up to the hype?NASDAQ:ASTSNASDAQ:RKLBNASDAQ:TMUSRead AST SpaceMobile Stock Surges 17% After Analyst UpgradeFebruary 26, 2025 9:20 AM ETSMCI Investors Use These ETFs For Heightened ExposureNathan ReiffSuper Micro Computer is one of the most talked-about companies today; these three ETFs give investors other means of accessing the firm's stock performance.NASDAQ:SMCINASDAQ:SMCXNYSEARCA:SMCXRead SMCI Investors Use These ETFs For Heightened ExposureFebruary 25, 2025 6:00 AM ETConfluent: How Data Streaming May Transform AINathan ReiffConfluent's earnings performance, its strong guidance, and its exciting partnership with Databricks—with the potential to transform AI—make it a must-watch.NASDAQ:CFLTNYSE:MSNYSE:UBSRead Confluent: How Data Streaming May Transform AIFebruary 24, 2025 7:06 AM ETThese 3 Unusual ETFs Have Dominated the S&P 500's Performance YTDNathan ReiffThree unusual ETFs may have strategies that are unorthodox, but their impact is very real: these funds have all solidly beat the market so far this year.NYSEARCA:SNOYNYSEARCA:FCUSNASDAQ:NERDRead These 3 Unusual ETFs Have Dominated the S&P 500's Performance YTDFebruary 24, 2025 5:30 AM ET3 Stocks Offering Strong Value and StabilityNathan ReiffThese stocks may be undervalued based on recent price activity, new partnerships, or disappointing earnings that mask strong underlying performance.NYSE:DHRNASDAQ:MGNINYSE:DBDRead 3 Stocks Offering Strong Value and StabilityFebruary 21, 2025 6:02 AM ET2 S&P 500 ETFs for Growth and Leverage in a Hot MarketNathan ReiffWith the great returns of the S&P 500 in recent months, investors looking for something more from the index have two trending ETFs to consider.NYSEARCA:SPYGNASDAQ:AAPLNASDAQ:NVDARead 2 S&P 500 ETFs for Growth and Leverage in a Hot MarketFebruary 21, 2025 5:38 AM ET3 Precious Metals ETFs Gaining Big as Gold Nears New HighsNathan ReiffPrecious metals have surged, with gold seeing all-time highs this year; these three ETFs can help to provide easy exposure to the rally.NYSEARCA:UGLNYSEARCA:DBPNASDAQ:RINGRead 3 Precious Metals ETFs Gaining Big as Gold Nears New HighsFebruary 17, 2025 6:30 AM ETKyndryl Soars on AI, Cybersecurity Growth—What’s Next?Nathan ReiffKyndryl's major partnerships with Palo Alto Networks, Microsoft, and others, combined with its rapidly growing Consult business, fuel analyst optimism.NYSE:KDNYSE:IBMNASDAQ:MSFTRead Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?February 17, 2025 5:45 AM ETATN International: A Deep Value Play With a High-Powered DividendNathan ReiffATN International is a telecom infrastructure firm providing service to rural and underdeveloped areas; it may also draw investors for its value prospects.NASDAQ:ATNIRead ATN International: A Deep Value Play With a High-Powered DividendFebruary 15, 2025 5:00 AM ET3 Consumer Staples ETFs for Stability in a Volatile MarketNathan ReiffIf the market environment seems a little too uncertain, a risk-averse investor might consider these three consumer staples ETFs to help ride out the turbulence.NASDAQ:PSLNYSEARCA:XLPNASDAQ:COSTRead 3 Consumer Staples ETFs for Stability in a Volatile MarketFebruary 14, 2025 5:15 AM ETBiotechs on the Brink: 2 Stocks With Huge PotentialNathan ReiffBriaCell Therapeutics and Recursion Pharmaceuticals are two biotech firms that may be poised for success in 2025; risk-tolerant investors might keep an eye out.NASDAQ:BCTXNASDAQ:DRUGNASDAQ:RXRXRead Biotechs on the Brink: 2 Stocks With Huge PotentialFebruary 12, 2025 6:00 AM ET3 Dividend ETFs to Maximize Passive IncomeNathan ReiffDividend stocks appeal to investors for their easy access to passive income; these three ETFs provide dividend-like passive income with high yields.NYSEARCA:YYYNASDAQ:FTQINASDAQ:KBWDRead 3 Dividend ETFs to Maximize Passive IncomeFebruary 11, 2025 5:30 AM ETFintech vs. Traditional Finance: Showdown of Nu, SoFi, and ChubbNathan ReiffFintech firms continue to fight for dominance; here we take a look at two recent contenders, comparing them against a long-standing insurance dividend play.NYSE:NUNASDAQ:SOFINYSE:CBRead Fintech vs. Traditional Finance: Showdown of Nu, SoFi, and ChubbFebruary 10, 2025 5:45 AM ET2 Defensive Energy Stocks to Hedge Against Trade TurmoilNathan ReiffTwo energy sector firms may appeal to investors looking for stability during a period of broad uncertainty about U.S. tariffs and their impact on markets.NASDAQ:TLNNYSE:BACNYSE:CWENRead 2 Defensive Energy Stocks to Hedge Against Trade TurmoilFebruary 10, 2025 5:30 AM ET3 Mining Stocks Poised to Ride the Precious Metals BoomNathan ReiffMining stocks are poised to benefit from an ongoing rally in precious metals fueled by all-time high gold prices; these firms stand out from the pack.NYSE:CDENYSE:ALGTSE:AGIRead 3 Mining Stocks Poised to Ride the Precious Metals BoomFebruary 7, 2025 8:42 AM ETHigh-Momentum ETFs Leading the Market This YearNathan ReiffMomentum investors looking to start 2025 off on good footing might look no further than these high-flying ETFs, each of which has returned 14% or more in 2025.NYSEARCA:BTGDNYSEARCA:PSILNYSEARCA:NUKZRead High-Momentum ETFs Leading the Market This YearFebruary 5, 2025 10:02 AM ETSeeking Stability? These 3 Stocks Offer Strong PotentialNathan ReiffConsumer staples companies may offer some protection against volatility during times of tariff uncertainty; these stocks could be a defensive play.NYSE:CAGNYSE:KNASDAQ:TLRYRead Seeking Stability? These 3 Stocks Offer Strong PotentialFebruary 4, 2025 5:00 AM ETTop 3 High-Momentum Companies Analysts Are Still Bullish OnNathan ReiffMomentum investors seek to take advantage of share price rallies to buy companies before they peak; analysts think these three firms still have room to grow.NASDAQ:CMPXNASDAQ:AVAVNASDAQ:ALLTRead Top 3 High-Momentum Companies Analysts Are Still Bullish OnFebruary 3, 2025 7:35 AM ETCan Palladyne AI Live Up to the Hype?Nathan ReiffPalladyne AI was one of the hottest stocks in 2024, surging by about 1,600%; while there are reasons to support the hype, there are also reasons to be cautious.NASDAQ:PDYNNASDAQ:NVDANASDAQ:RCATRead Can Palladyne AI Live Up to the Hype?February 3, 2025 6:00 AM ET3X-Leveraged ETFs: Amplify Returns With These 3 Top PicksNathan ReiffLeveraged ETFs are not designed for casual or buy-and-hold investors due to their heightened risk; however, for experienced investors they can be a strong play.NYSEARCA:SOXLNYSEARCA:DFENNYSEARCA:OILURead 3X-Leveraged ETFs: Amplify Returns With These 3 Top PicksFebruary 3, 2025 5:45 AM ET3 Underrated Robotics Stocks Poised for Major GrowthNathan ReiffRobotics firms that may deserve a closer look by investors include AeroVironment, Cognex, and Myomo, all of which offer compelling products and tech.NASDAQ:AVAVNASDAQ:CGNXNYSEAMERICAN:MYORead 3 Underrated Robotics Stocks Poised for Major GrowthFebruary 3, 2025 5:00 AM ET3 REITs to Watch as Interest Rates Keep FallingNathan ReiffREITs make a strong choice during periods of relatively low interest rates thanks to their reliance on debt and their dividend payouts.NASDAQ:EQIXNYSE:AMTNYSE:DLRRead 3 REITs to Watch as Interest Rates Keep FallingJanuary 28, 2025 6:45 AM ETWhat Does the Future Hold for Eli Lilly?Nathan ReiffEli Lilly's two major GLP-1 drugs have dominated headlines, but a slate of new treatments in development—and some already available—suggest a bright future.NYSE:LLYNYSE:NVORead What Does the Future Hold for Eli Lilly? Page 6 of 11 « Most Recent‹ More Recent3456789 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
